Work

Intermittent erlotinib (ERL) in combination with pemetrexed (PEM): Phase I schedules designed to achieve pharmacodynamic separation

Year: 2008

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2008.26.15_suppl.8032

Authors: A. M. Davies, C. Ho, L. Beckett, D. H. Lau, S. Scudder, P. N. Lara, N. Perkins, D. R. Gandara

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2242998313

Cites:

Cited by: 7

Related to: 10